November 13, 2018
CRISPR Cas-9 gene editing is finally in clinical studies. Here's an overview of CRISPR genetics testing trials currently in progress.
April 19, 2018
With Q1 2018 officially in the books, here the Investing News Network takes a look back at what some of...
February 22, 2017
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today reported its results for the fourth quarter...
November 20, 2016
The week's top gainer was Ocular Therapeutix, followed by Cara Therapeutics, Immunomedics, Rockwell Medical and Array BioPharma.
November 13, 2016
Last week's top gainer was PTC Therapeutics followed by Cogentix Medical, Concordia International, Galectin Therapeutics and XOMA.
November 6, 2016
Last week's top gainer was AveXis, Inc. followed by Heska Corp., Corcept Therapeutics, Atara Biotherapeutics and Seattle Genetics Inc.
October 30, 2016
Last week's top gainer was Alexion Pharmaceuticals, followed by LeMaitre Vascular, NeoGenomics Inc, United Therapeutics Corp. and Mesa Laboratories.